Key result
Brugada ECG pattern linked to ANK2 variant in Myotonic Dystrophy Type 2 patients.
Why the study?
The association between Brugada syndrome and myotonic dystrophy type 2 (DM2) remains largely unexplored.
Case Report (n=1)
This case expands the spectrum of Brugada phenotypes to myotonic dystrophy type 2 and highlights the importance of evaluating suspicious Brugada-like ECG findings in patients with muscular dystrophies.
Answers are grounded in this paper and cite their sources.
May warrant ECG caution in myotonic dystrophy type 2; leaves open ANK2 causality in Brugada pattern pending validation.
BACKGROUND: Brugada syndrome has been reported in myotonic dystrophy type 1, whereas its association with myotonic dystrophy type 2 (DM2) remains largely unexplored. CASE SUMMARY: We report a patient with genetically confirmed DM2 who presented with an electrocardiogram showing a Brugada type-2 ECG pattern. Sodium-channel blocker testing unmasked a diagnostic type 1 Brugada pattern. Genetic analysis excluded SCN5A variants and identified a rare heterozygous ANK2 missense variant, a gene involved in cardiac electrical stability. CONCLUSION: This case expands the spectrum of Brugada phenotypes to DM2 and highlights the importance of not underestimating suspicious Brugada-like ECG findings in patients with muscular dystrophies.
No takes yet. Share an insight, caveat, or question.
d'Apolito et al. (2026) conducted a case report in Myotonic dystrophy type 2 (DM2) (n=1). Sodium-channel blocker testing was evaluated on Unmasking of type 1 Brugada pattern and genetic variant identification. Sodium-channel blocker testing unmasked a diagnostic type 1 Brugada pattern in a patient with myotonic dystrophy type 2, revealing a rare heterozygous ANK2 missense variant.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: